ABBV
- AbbVie Inc.
()
Overview
Company Summary
AbbVie Inc. is a global pharmaceutical company that specializes in the research, development, and manufacturing of prescription drugs and pharmaceutical products. The company focuses on finding solutions and innovations in areas such as immunology, oncology, neuroscience, virology, and general medicine.
AbbVie operates in various therapeutic areas and offers a wide range of products to treat different medical conditions. Some of its well-known drugs include Humira (adalimumab), an immunosuppressive medication used for treating autoimmune diseases like rheumatoid arthritis and Crohn's disease. It is among the top-selling pharmaceutical products worldwide.
Additionally, AbbVie has a strong presence in the field of oncology. They develop and market drugs for the treatment of various cancers, including leukemia, lymphoma, and solid tumors. Another notable drug in their portfolio is Imbruvica (ibrutinib), used for treating certain types of blood cancers.
The company is committed to ongoing research and development efforts to discover new therapies and treatments. They invest heavily in innovation and collaborations with healthcare professionals, academic institutions, and other organizations in order to advance medical science and improve patient outcomes.
AbbVie also focuses on ensuring access to healthcare and affordability of their medications. They work to expand patient access to their treatments, particularly in underprivileged communities, through patient assistance programs and pricing initiatives.
In summary, AbbVie Inc. is a pharmaceutical company dedicated to developing and delivering innovative prescription drugs and pharmaceutical products to help patients manage a variety of medical conditions, with a particular emphasis on immunology, oncology, neuroscience, virology, and general medicine.